威高骨科
(688161)
| 流通市值：90.44亿 | | | 总市值：90.44亿 |
| 流通股本：4.00亿 | | | 总股本：4.00亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 704,424,329.89 | 296,330,838.73 | 1,522,794,046.97 | 1,106,261,911.75 |
| 营业总成本 | 553,854,159.55 | 253,047,152.6 | 1,208,242,886.13 | 863,391,351.16 |
| 其他经营收益 | | | | |
| 营业利润 | 159,448,397.73 | 52,551,713.95 | 323,417,093.29 | 252,229,587.95 |
| 利润总额 | 159,681,464.75 | 52,605,356.14 | 324,065,742.4 | 251,768,499.45 |
| 净利润 | 131,758,613.97 | 43,313,537.7 | 273,804,737.67 | 211,174,126.68 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 131,758,613.97 | 43,313,537.7 | 273,804,737.67 | 211,174,126.68 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 4,004,981,544.73 | 4,339,966,495.4 | 4,308,432,940.21 | 4,364,419,559.1 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,199,430,528.85 | 850,695,065.97 | 752,628,351.36 | 728,846,024.19 |
| 资产总计 | 5,204,412,073.58 | 5,190,661,561.37 | 5,061,061,291.57 | 5,093,265,583.29 |
| 流动负债: | | | | |
| 流动负债合计 | 926,913,442.82 | 911,934,756.54 | 863,314,910.38 | 876,429,032.59 |
| 非流动负债: | | | | |
| 非流动负债合计 | 48,189,829.76 | 49,792,911.61 | 38,354,004.04 | 130,015,771.14 |
| 负债合计 | 975,103,272.58 | 961,727,668.15 | 901,668,914.42 | 1,006,444,803.73 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,195,271,073.69 | 4,195,339,327.3 | 4,144,501,201.66 | 4,073,322,439.44 |
| 股东权益合计 | 4,229,308,801 | 4,228,933,893.22 | 4,159,392,377.15 | 4,086,820,779.56 |
| 负债和股东权益合计 | 5,204,412,073.58 | 5,190,661,561.37 | 5,061,061,291.57 | 5,093,265,583.29 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 720,876,040.5 | 341,706,544.99 | 1,738,010,378.81 | 1,168,314,826.82 |
| 经营活动现金流出小计 | 580,460,538.39 | 304,733,534.99 | 1,322,593,268.16 | 917,913,428.71 |
| 经营活动产生的现金流量净额 | 140,415,502.11 | 36,973,010 | 415,417,110.65 | 250,401,398.11 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,644,565,479.97 | 975,491,671.75 | 4,395,604,576.58 | 3,359,918,047.63 |
| 投资活动现金流出小计 | 2,923,175,111.55 | 938,510,166.55 | 5,013,786,757.74 | 3,717,665,357.94 |
| 投资活动产生的现金流量净额 | -278,609,631.58 | 36,981,505.2 | -618,182,181.16 | -357,747,310.31 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 50,000 | 50,000 | - | - |
| 筹资活动现金流出小计 | 86,713,228.94 | 3,868,732.48 | 239,994,024.06 | 92,113,048.73 |
| 筹资活动产生的现金流量净额 | -86,663,228.94 | -3,818,732.48 | -239,994,024.06 | -92,113,048.73 |
| 汇率变动对现金及现金等价物的影响 | -2,737,638.92 | -1,343,602.81 | -867,124.91 | -1,003,027.95 |
| 现金及现金等价物净增加额 | -227,594,997.33 | 68,792,179.91 | -443,626,219.48 | -200,461,988.88 |
| 期末现金及现金等价物余额 | 1,018,598,746 | 1,314,985,923.24 | 1,246,193,743.33 | 1,489,357,973.93 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -227,594,997.33 | - | -443,626,219.48 | - |